Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit behind this grim statistic is its immunosuppressive tumor microenvironment ...
Cancer researchers at Fox Chase Cancer Center see promise in personalized medicine to help crack the code on improving diagnosis and treatment options for pancreatic cancer.